Bladder dysfunction in mice with experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 203, Issue 1, 2008, Pages 58-63

  Altuntas, Cengiz Z ^a   Daneshgari, Firouz ^a   Liu, Guiming ^a   Fabiyi, Adebola ^a   Kavran, Michael ^a   Johnson, Justin M ^a   Gulen, M Fatih ^a   Jaini, Ritika ^a   Li, Xiaoxia ^a   Frenkl, Tara L ^a   Tuohy, Vincent K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmune; EAE MS; Micturition; Neurogenic bladder

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DYSFUNCTION; BLADDER FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; FEMALE; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; NEUROGENIC BLADDER; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; URINARY FREQUENCY; URINE VOLUME;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; MUSCLE HYPERTONIA; SPINAL CORD; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; URINATION; URINE;

EID: 52949151878     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.06.038     Document Type: Article

References (30)

1. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., Van Kerrebroeck P., Victor A., and Wein A. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61 (2003) 37-49
2. Ahmed H.U., Shergill I.S., Arya M., and Shah P.J. Management of detrusor-external sphincter dyssynergia. Nat. Clin. Pract. Urol. 3 (2006) 368-380
3. Andersson K.E., Chapple C., and Wein A. The basis for drug treatment of the overactive bladder. World J. Urol. 19 (2001) 294-298
4. Athwal B.S., Berkley K.J., Hussain I., Brennan A., Craggs M., Sakakibara R., Frackowiak R.S., and Fowler C.J. Brain responses to changes in bladder volume and urge to void in healthy men. Brain 124 (2001) 369-377
5. Birder L., Apodaca G., De Groat W.C., and Kanai A.J. Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am. J. Physiol. 275 (1998) 226-229
6. Blaivas J.G., and Barbalias G.A. Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition. J. Urol. 131 (1984) 91-94
7. Blok B.F.M., Willemsen A.T., and Holstege G. A PET study on brain control of micturition in humans. Brain 120 (1997) 111-121
8. Blok B.F.M., Sturms L.M., and Holstege G. Brain activation during micturition in women. Brain 121 (1998) 2033-2042
9. Blok B.F.M. Central pathways controlling micturition and urinary continence. Urology 59 (2002) 13-17
10. Fernandez O. Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis. J. Neurol. 249 (2002) 1-8
11. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., and Baecher-Allan C. Multiple sclerosis. Immunol. Rev. 204 (2005) 208-231
12. Kalsi V., and Fowler C.J. Therapy insight: bladder dysfunction associated with multiple sclerosis. Nat. Clin. Pract. Urol. 2 (2005) 492-501
13. Koldewijn E.L., Hommes O.R., Lemmens W.A., Debruyne F.M., and van Kerrebroeck P.E. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J. Urol. 154 (1995) 169-173
14. Lifson J.D., Oyasu R., Dreyer N., Carone F.A., and Williams R.M. Acute hemorrhagic obstructive uropathy as a complication of experimental autoimmune encephalomyelitis. Arch. Pathol. Lab. Med. 107 (1983) 600-602
15. Litwiller S.E., Frohman E.M., and Zimmern P.E. Multiple sclerosis and the urologist. J. Urol. 161 (1999) 743-757
16. Liu X., Zhao Y., Pawlyk B., Damaser M., and Li T. Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am. J. Pathol. 168 (2006) 519-528
17. Matsuura S., Kakizaki H., Mitsui T., Shiga T., Tamaki N., and Koyanagi T. Human brain region response to distention or cold stimulation of the bladder: a positron emission tomography study. J. Urol. 168 (2002) 2035-2039
18. Mizusawa H., Igawa Y., Nishizawa O., Ichikawa M., Ito M., and Andersson K.E. A rat model for investigation of bladder dysfunction associated with demyelinating disease resembling multiple sclerosis. Neurourol. Urodyn. 19 (2000) 689-699
19. Nortvedt M.W., Riise T., Myhr K.M., Landtblom A.M., Bakke A., and Nyland H.I. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult. Scler. 7 (2001) 231-235
20. Peterson L.K., and Fujinami R.S. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 184 (2007) 37-44
21. Prosiegel M., Schelling A., and Wagner-Sonntag E. Dysphagia and multiple sclerosis. Int.MS. J. 11 (2004) 22-31
22. Sobel R.A., Tuohy V.K., Lu Z., Laursen R.A., and Lees M.B. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J. Neuropath. Exper. Neurol. 49 (1990) 468-479
23. Steinman L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2 (2001) 762-764
24. Steinman L., and Zamvil S.S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26 (2005) 565-571
25. Swanborg R.H. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol. Rev. 184 (2001) 129-135
26. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., and Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142 (1989) 1523-1527
27. Vignes J.R., Deloire M.S., Petry K.G., and Nagy F. Characterization and restoration of altered inhibitory and excitatory control of micturition reflex in experimental autoimmune encephalomyelitis in rats. J. Physiol. 578 (2007) 439-450
28. Wujek J.R., Bjartmar C., Richer E., Ransohoff R.M., Yu M., Tuohy V.K., and Trapp B.D. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropath. Exper. Neurol. 61 (2002) 23-32
29. Yamamoto T., Sakakibara R., Uchiyama T., Liu Z., Ito T., Awa Y., Yamanishi T., and Hattori T. Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol. Urodyn. 25 (2006) 356-360
30. Yu M., Johnson J.M., and Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183 (1996) 1777-1788